Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1305 Electrophysiology Study in Atrial Flutter
NCT00616629Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2008
- Primary completion
- Jun 2008
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 2 trial of AZD-1305 in atrial flutter (AFL), sponsored by AstraZeneca. Started Jan 2008; status: completed.
02
Drugs
AZD-1305
03
Conditions
atrial flutter (AFL)
Beyond the preview
Go deeper on NCT00616629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00616629.